CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
05 déc. 2019 07h00 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD...
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
30 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD...
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
01 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the...
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
30 avr. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap...
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
01 avr. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire...
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
29 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board...
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
09 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
01 nov. 2018 07h25 HE
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
28 sept. 2018 07h25 HE
|
CURE Pharmaceutical
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's MicroCap Conference on October...
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
05 sept. 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year...